When is hormone replacement therapy recommended for postmenopausal osteoporosis?

After menopause, lower oestrogen can speed the loss of bone strength. Hormone replacement therapy can slow this process while also easing symptoms such as hot flushes. It is not automatically the first choice for every person with osteoporosis, and its possible effects on the breast, womb lining, blood vessels, and other organs must be weighed against expected benefit.

The decision depends on fracture history, bone density assessment, age, time since menopause, symptoms, and health conditions. Other medicines specifically used to strengthen bone may be more suitable, especially when hormone treatment is not appropriate.

Ask for an assessment of fracture risk and the cause of bone loss. Share any history of blood clots, stroke, liver disease, unexplained vaginal bleeding, breast cancer, or womb problems, as these can change the treatment choice. Discuss calcium and vitamin D intake, muscle-strengthening activity, balance exercises, smoking, alcohol, and fall prevention.

If hormone replacement therapy is chosen, ask about the route, whether a progestogen is needed, how bone health will be monitored, and when the plan should be reviewed. Do not stop prescribed treatment without discussing it with the prescriber.

Report new vaginal bleeding after menopause, severe or persistent breast changes, or unexplained pelvic pain. Seek urgent help for chest pain, sudden breathlessness, coughing blood, one-sided leg swelling, sudden weakness, or a severe headache with neurological symptoms.

A fall that causes significant pain, inability to bear weight, or a suspected fracture needs prompt assessment. New pain in the back, hip, or wrist can sometimes signal a fracture even when the injury seemed minor.

Ask: What is my fracture risk? Why is hormone replacement therapy suitable for me? Are bone-specific medicines preferable? How will you monitor bone density and bleeding? What symptoms should trigger an urgent call?